Skip to main content
SpringerLink
Log in

Treating high grade gliomas in the elderly: the end of ageism?

  • Clinical-patient studies
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Introduction Treating high grade gliomas in the elderly is a challenge for multidisciplinary teams. Most studies on this topic exclude patients aged >65 and a Karnofsky Performance Status (KPS) score of <70, a group most likely to have a poor outcome. We undertook this study to analyze the outcomes in a cohort of patients which included such patients. Methods Ours was a retrospective cohort study. About 71 consecutive patients with high grade gliomas, who were seen in the neurooncology clinic in 2004, were included. The case records of these patients were scrutinized for the demographic, clinical data, follow-up and survival. The cohort was divided into two groups; Age ≥65 and age <65 for analysis. The factors influencing survival were analyzed using the Cox’s proportional hazards model in each group. Results In the age group ≥65 years, patients treated with a radical resection ± adjuvant therapy had a lower risk of death (hazard ratio 0.14, 95%CI 0.04–0.51, P = 0.003) when compared to patients undergoing a biopsy ± adjuvant therapy and palliative treatment. In the group <65 years, the greater the age, greater was the risk of death (hazard ratio 2.05, 95%CI 1.13–3.73, P = 0.01). The median survival was 12 months in the group <65 years and 5 months in age ≥65 years (P = 0.001). In the group ≥65 years, those patients who had radical resection ± adjuvant treatment had a median survival of 7 months as compared to 3 months in the patients who had biopsy ± adjuvant treatment (P = 0.003). KPS, presence of co-morbidities, duration of symptoms, location of the lesion and sex were not found to be significant independent predictors of survival in our study. Conclusions Age is an important predictor of survival in younger patients, however in the elderly treatment matters most. Elderly patients undergoing radical surgery ± adjuvant treatment had a longer median survival as compared to the elderly patients undergoing a biopsy ± adjuvant treatment. KPS was not found to be a significant independent predictor of survival probably because of underrepresentation of patients with poor KPS. Radical treatment should not be denied to elderly patients who are deemed fit as the outcome is significantly better.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Brandes AA, Monfardini S (2003) The treatment of elderly patients with high-grade gliomas. Semin Oncol 30:58–62

    Article  PubMed  Google Scholar 

  2. Brandes AA, Vastola F, Basso U, Berti F, Pinna G, Rotilio A, Gardiman M, Scienza R, Monfardini S, Ermani M (2003) A prospective study on glioblastoma in the elderly. Cancer 97:657–662

    Article  PubMed  Google Scholar 

  3. Fernandez PM, Brem S (1997) Malignant brain tumors in the elderly. Clin Geriatr Med 13:327–338

    PubMed  CAS  Google Scholar 

  4. Kleinschmidt-DeMasters BK, Lillehei KO, Varella-Garcia M (2005) Glioblastomas in the older old. Arch Pathol Lab Med 129:624–631

    PubMed  CAS  Google Scholar 

  5. Lowry JK, Snyder JJ, Lowry PW (1998) Brain tumors in the elderly: recent trends in a Minnesota cohort study. Arch Neurol 55:922–928

    Article  PubMed  CAS  Google Scholar 

  6. Lutterbach J, Bartelt S, Momm F, Becker G, Frommhold H, Ostertag C (2005) Is older age associated with a worse prognosis due to different patterns of care? A long-term study of 1346 patients with glioblastomas or brain metastases. Cancer 103:1234–1244

    Article  PubMed  Google Scholar 

  7. Mangiola A, Maira G, De Bonis P, Porso M, Pettorini B, Sabatino G, Anile C (2006) Glioblastoma multiforme in the elderly: a therapeutic challenge. J Neurooncol 76:159–163

    Article  PubMed  CAS  Google Scholar 

  8. Patwardhan RV, Shorter C, Willis BK, Reddy P, Smith D, Caldito GC, Nanda A (2004) Survival trends in elderly patients with glioblastoma multiforme: resective surgery, radiation, and chemotherapy. Surg Neurol 62:207–213; discussion 214–205

    Article  PubMed  Google Scholar 

  9. Pierga JY, Hoang-Xuan K, Feuvret L, Simon JM, Cornu P, Baillet F, Mazeron JJ, Delattre JY (1999) Treatment of malignant gliomas in the elderly. J Neurooncol 43:187–193

    Article  PubMed  CAS  Google Scholar 

  10. Whittle IR, Denholm SW, Gregor A (1991) Management of patients aged over 60 years with supratentorial glioma: lessons from an audit. Surg Neurol 36:106–111

    Article  PubMed  CAS  Google Scholar 

  11. Davis DL, Hoel D, Fox J, Lopez A (1990) International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA. Lancet 336:474–481

    Article  PubMed  CAS  Google Scholar 

  12. Davis DL, Hoel D, Fox J, Lopez AD (1990) International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the United States. Ann N Y Acad Sci 609:5–48

    Article  PubMed  CAS  Google Scholar 

  13. Davis DL, Hoel D, Percy C, Ahlbom A, Schwartz J (1990) Is brain cancer mortality increasing in industrial countries? Ann N Y Acad Sci 609:191–204

    Article  PubMed  CAS  Google Scholar 

  14. Deorah S, Lynch CF, Sibenaller ZA, Ryken TC (2006) Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. Neurosurg Focus 20:E1

    Article  PubMed  Google Scholar 

  15. Claus EB, Black PM (2006) Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973–2001. Cancer 106:1358–1363

    Article  PubMed  Google Scholar 

  16. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190–198

    PubMed  CAS  Google Scholar 

  17. Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, Lillehei KO, Bernstein M, Brem H, Sloan A, Berger MS, Chang S (2003) Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 99:467–473

    PubMed  Google Scholar 

  18. Hutchins LF, Unger JM, Crowley JJ, Coltman CA Jr., Albain KS (1999) Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341:2061–2067

    Article  PubMed  CAS  Google Scholar 

  19. Prognostic factors for high-grade malignant glioma: development of a prognostic index (1990) A report of the medical research council brain tumour working party. J Neurooncol 9:47–55

    Article  Google Scholar 

  20. Sawaya R (1999) Extent of resection in malignant gliomas: a critical summary. J Neurooncol 42:303–305

    Article  PubMed  CAS  Google Scholar 

  21. Sawaya R, Hammoud M, Schoppa D, Hess KR, Wu SZ, Shi WM, Wildrick DM (1998) Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42:1044–1055; discussion 1055–1046

    Article  PubMed  CAS  Google Scholar 

  22. Lutterbach J, Sauerbrei W, Guttenberger R (2003) Multivariate analysis of prognostic factors in patients with glioblastoma. Strahlenther Onkol 179:8–15

    PubMed  Google Scholar 

  23. Shaw EG (2004) Nothing ventured, nothing gained: treatment of glioblastoma multiforme in the elderly. J Clin Oncol 22:1540–1541

    Article  PubMed  Google Scholar 

  24. Nishihara M, Taomoto K, Kohmura E (2005) Prognostic factors in malignant glioma in elderly patients. Nippon Rinsho 63(Suppl 9):596–599

    PubMed  Google Scholar 

  25. Counsell CE, Collie DA, Grant R (1996) Incidence of intracranial tumours in the Lothian region of Scotland, 1989–90. J Neurol Neurosurg Psychiatr 61:143–150

    PubMed  CAS  Google Scholar 

  26. Greig NH, Ries LG, Yancik R, Rapoport SI (1990) Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst 82:1621–1624

    Article  PubMed  CAS  Google Scholar 

  27. Annegers JF, Schoenberg BS, Okazaki H, Kurland LT (1981) Epidemiologic study of primary intracranial neoplasms. Arch Neurol 38:217–219

    PubMed  CAS  Google Scholar 

  28. Modan B, Wagener DK, Feldman JJ, Rosenberg HM, Feinleib M (1992) Increased mortality from brain tumors: a combined outcome of diagnostic technology and change of attitude toward the elderly. Am J Epidemiol 135:1349–1357

    PubMed  CAS  Google Scholar 

  29. Piccirilli M, Bistazzoni S, Gagliardi FM, Landi A, Santoro A, Giangaspero F, Salvati M (2006) Treatment of glioblastoma multiforme in elderly patients. Clinico-therapeutic remarks in 22 patients older than 80 years. Tumori 92:98–103

    PubMed  Google Scholar 

  30. Buckner JC (2003) Factors influencing survival in high-grade gliomas. Semin Oncol 30:10–14

    Article  PubMed  Google Scholar 

  31. Uzuka T, Tanaka R, Takahashi H (2005) Treatment of malignant gliomas in the elderly. Nippon Rinsho 63(Suppl 9):591–595

    PubMed  Google Scholar 

  32. Polin RS, Marko NF, Ammerman MD, Shaffrey ME, Huang W, Anderson FA Jr., Caputy AJ, Laws ER (2005) Functional outcomes and survival in patients with high-grade gliomas in dominant and nondominant hemispheres. J Neurosurg 102:276–283

    PubMed  Google Scholar 

  33. Nazzaro JM, Neuwelt EA (1990) The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg 73:331–344

    Article  PubMed  CAS  Google Scholar 

  34. Laws ER, Shaffrey ME, Morris A, Anderson FA Jr. (2003) Surgical management of intracranial gliomas–does radical resection improve outcome? Acta Neurochir Suppl 85:47–53

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neuro-Oncology Services, Department of Neurosurgery (NM, DR, GH, PJK) and Oncology (PRCD), James Cook University Hospital, Marton Road, Middlesbrough, TS4 3BW, UK

    Nitin Mukerji, Desiderio Rodrigues, Gill Hendry, Peter R. C. Dunlop & Philip J. Kane

  2. Department of Research and Development, Barts and the London NHS Trust, London, UK

    Fiona Warburton

Authors
  1. Nitin Mukerji
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Desiderio Rodrigues
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gill Hendry
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peter R. C. Dunlop
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fiona Warburton
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Philip J. Kane
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Philip J. Kane.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mukerji, N., Rodrigues, D., Hendry, G. et al. Treating high grade gliomas in the elderly: the end of ageism?. J Neurooncol 86, 329–336 (2008). https://doi.org/10.1007/s11060-007-9476-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-007-9476-2

Keywords

Search

Navigation